Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Jing, Jiaojiaoa; 1 | Zhang, Fenga; c; 1 | Zhao, Lia; 1 | Xie, Jinghuib | Chen, Jianwena | Zhong, Rujiac | Zhang, Yanjunb; * | Dong, Chunboa; *
Affiliations: [a] Department of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian, China | [b] Department of Nuclear Medicine, the First Affiliated Hospital, Dalian Medical University, Dalian, China | [c] First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
Correspondence: [*] Correspondence to: Chunbo Dong, No. 222 Zhongshan Road. Department of Neurology, the First Affiliated Hospital, Dalian Medical University, Dalian 116021, China. Tel.: +86 83635963 3083; E-mail: [email protected]. Yanjun Zhang, No. 222 Zhongshan Road, Department of Nuclear Medicine, the First Affiliated Hospital, Dalian Medical University, Dalian, China. Tel.: 0411 84394202; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background:Florbetapir (AV45) and fluorodeoxyglucose (FDG) PET imaging are valuable techniques to detect the amyloid-β (Aβ) load and brain glucose metabolism in patients with Alzheimer’s disease (AD). Objective:The purpose of this study is to access the characteristics of Aβ load and FDG metabolism in brain for further investigating their relationships with cognitive impairment in AD patients. Methods:Twenty-seven patients with AD (average 70.6 years old, N = 13 male, N = 14 female) were enrolled in this study. These AD patients underwent the standard clinical assessment and received detailed imaging examinations of the nervous system by using Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MOCA), 18F-AV45, and 18F-FDG PET scans. Results:Of 27 AD patients, 22 patients (81.5%) showed significantly increases in Aβ load and 26 patients (96.3%) had significantly reductions in FDG metabolism. The moderate AD patients had more brain areas of reduced FDG metabolism and more severe reductions in some regions compared to mild AD patients, with no differences in Aβ load observed. Moreover, the range and degree of reduced FDG metabolism in several regions were positively correlated with the total score of MMSE or MOCA, whereas the range of Aβ load did not. No correlation was found between the range of Aβ load and the range of reduced FDG metabolism in this study. Conclusion:The reduction in FDG metabolisms captured by 18F-FDG imaging can be used as a potential biomarker for AD diagnosis in the future. 18F-AV45 imaging did not present valuable evidence for evaluating AD patient in this study.
Keywords: Alzheimer’s disease, amyloid-β load, AV45, glucose metabolism, PET
DOI: 10.3233/JAD-201335
Journal: Journal of Alzheimer's Disease, vol. 79, no. 3, pp. 1317-1325, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]